Extended Data Fig. 7: KEGG enrichment results (top 20).
From: A method for predicting drugs that can boost the efficacy of immune checkpoint blockade
The top 20 enriched pathways of the upregulated DEGs between responders (R) and non-responders (NR) for the single use of anti-PD-1 (a), single use of taltirelin (b), and combination treatment groups (c), respectively. d, KEGG enrichment results (q-value and hit count) of the ‘Autoimmune thyroid disease’ on DEGs between R and NR samples from monotherapy group or combination-treated group. e, Schematic diagram of genes in KEGG thyroid-related pathways overlapping with Core & Minor genes.
